Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore
- PMID: 11854433
- DOI: 10.1124/mol.61.3.533
Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore
Abstract
A large number of structurally diverse compounds act as open-channel blockers of NMDA receptors. They may share discrete or overlapping binding sites within the channel. In this study, the effects of mutations in and around the membrane-spanning and pore-forming regions of NMDA receptor subunits were studied with three blockers, MK-801, memantine, and TB-3-4, using recombinant NMDA receptors expressed in Xenopus laevis oocytes. Mutations at the critical asparagine residues in the M2 loop of NR1 and NR2B and at a tryptophan residue in M2 of NR2B reduced block by MK-801, memantine, and TB-3-4. Mutations at residues in the pre-M1, M1, M3, post-M3, and post-M4 regions had differential effects on the three blockers. Many mutations in these regions reduced block by MK-801 and TB-3-4 but had no effect on block by memantine. The differential effects on block by memantine and MK-801 are unlikely to be caused by differences in the size of these blockers. Benzyl rings in MK-801 and TB-3-4 may make hydrophobic interactions with aromatic and hydrophobic amino acid residues in the pore. Some mutations in the pre-M1 and M3 regions generated constitutively open channels, characterized by large holding currents. The effects of the various mutants are discussed in the context of models based on the known structure of the pore of the KcsA potassium channel and on previous studies dealing with solvent accessible residues in NMDA receptor subunits as determined by modification after cysteine mutagenesis.
Similar articles
-
Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits.Mol Pharmacol. 1997 Oct;52(4):701-13. doi: 10.1124/mol.52.4.701. Mol Pharmacol. 1997. PMID: 9380034
-
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.Neuropharmacology. 2001 May;40(6):749-60. doi: 10.1016/s0028-3908(01)00008-9. Neuropharmacology. 2001. PMID: 11369029
-
Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.J Biol Chem. 2005 Aug 19;280(33):29708-16. doi: 10.1074/jbc.M414215200. Epub 2005 Jun 21. J Biol Chem. 2005. PMID: 15970596
-
[Memantine: a therapeutic drug for Alzheimer's disease and the comparison with MK-801].Nihon Yakurigaku Zasshi. 2004 Sep;124(3):145-51. doi: 10.1254/fpj.124.145. Nihon Yakurigaku Zasshi. 2004. PMID: 15333987 Review. Japanese.
-
Open-channel blockers of the NMDA receptor complex.Drug News Perspect. 2004 Nov;17(9):557-62. doi: 10.1358/dnp.2004.17.9.872569. Drug News Perspect. 2004. PMID: 15645013 Review.
Cited by
-
Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.J Neurosci. 2020 Jul 29;40(31):5922-5936. doi: 10.1523/JNEUROSCI.3010-19.2020. Epub 2020 Jul 1. J Neurosci. 2020. PMID: 32611707 Free PMC article.
-
Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.J Physiol. 2009 Oct 1;587(Pt 19):4589-604. doi: 10.1113/jphysiol.2009.176297. Epub 2009 Aug 17. J Physiol. 2009. PMID: 19687120 Free PMC article.
-
Computational Modeling of Therapy with the NMDA Antagonist in Neurodegenerative Disease: Information Theory in the Mechanism of Action of Memantine.Int J Environ Res Public Health. 2022 Apr 14;19(8):4727. doi: 10.3390/ijerph19084727. Int J Environ Res Public Health. 2022. PMID: 35457595 Free PMC article.
-
The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer's Disease-like Pathology.J Clin Med. 2022 Mar 27;11(7):1858. doi: 10.3390/jcm11071858. J Clin Med. 2022. PMID: 35407465 Free PMC article.
-
Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.J Med Chem. 2019 Jan 24;62(2):403-419. doi: 10.1021/acs.jmedchem.8b00714. Epub 2018 Aug 27. J Med Chem. 2019. PMID: 30110164 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources